Association of Hsa-mir-196 and Hsa-mir-153 Expression Levels With Gastric Cancer and H. pylori Infection

Moradi Nejad, Atefeh; Mokhtari, Negar; Zia Jahromi, Noosha

doi:10.30699/ijmm.18.3.163

year 18, Issue 3 (May - June 2024) Iran J Med Microbiol 2024, 18(3): 163-171 | Back to browse issues page

‎ 10.30699/ijmm.18.3.163

Mendeley

Zotero

RefWorks

Moradi Nejad A, Mokhtari N, Zia Jahromi N. Association of Hsa-mir-196 and Hsa-mir-153 Expression Levels With Gastric Cancer and H. pylori Infection. Iran J Med Microbiol 2024; 18 (3) :163-171
URL: http://ijmm.ir/article-1-2212-en.html

Association of Hsa-mir-196 and Hsa-mir-153 Expression Levels With Gastric Cancer and H. pylori Infection

Atefeh Moradi Nejad¹

, Negar Mokhtari²

, Noosha Zia Jahromi³

1- Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
2- Department of Biological Science and Technology, Najafabad Branch, Islamic Azad University, Najafabad, Iran
3- Department of Biology, Faculty of Basic Sciences, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran , nziajahromi@gmail.com

Abstract: (627 Views)

Background and Aim: Following genetic defects in cystic fibrosis (CF), mucus accumulation and hypoxic gradients develop in the lungs creating conditions for the anaerobic bacterial colonization. This study investigated the difference between the prevalence of some anaerobic bacteria and antibiotic resistance among healthy and CF groups.
Materials and Methods: In this case-control study, total RNA was extracted from blood samples of 40 GC patients with 29 H. pylori positive samples, and 40 healthy controls with 25 H. pylori positive individuals. The quantitative real-time polymerase chain reaction (qRT-PCR) was used to measure the expression levels of hsa-mir-196 and hsa-mir-153.
Results: Statistical analysis revealed a significant upregulation of hsa-mir-196 and a significant downregulation of hsa-mir-153 in the GC patients with H. pylori infection compared to those without infection and healthy controls.
Conclusion: In-silico analysis demonstrated the association of hsa-mir-196 and hsa-mir-153 with GC. These miRNAs are potential biomarkers for the GC associated with H. pylori infection and can serve as diagnostic tools for the early detection and may have prognostic value in predicting disease progression. However, further validation in larger cohorts and functional studies are necessary to fully understand their role in the GC development and assess their potential as therapeutic targets.

Keywords: Differentially Expressed Genes (DEGs), Gastric Cancer, Helicobacter pylori, hsa-mir-196, hsa-mir-153

Full-Text [PDF 615 kb] (218 Downloads) | | Full-Text (HTML) (94 Views)

Type of Study: Original Research Article | Subject: Medical Bacteriology
Received: 2024/04/3 | Accepted: 2024/08/1 | ePublished: 2024/08/18

References

1. Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534-42. [DOI:10.1016/j.cgh.2019.07.045] [PMID] [PMCID]

2. Mbulaiteye SM, Hisada M, El-Omar EM. Helicobacter pylori associated global gastric cancer burden. Front Biosci-Landmark. 2009;14(4):1490-504. [DOI:10.2741/3320] [PMID] [PMCID]

3. Go M. Natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther. 2002;16:3-15. [DOI:10.1046/j.1365-2036.2002.0160s1003.x] [PMID]

4. Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco F. H. pylori infection and gastric cancer: state of the art. Int J Oncol. 2013;42(1):5-18. [DOI:10.3892/ijo.2012.1701] [PMID]

5. Handa O, Naito Y, Yoshikawa T. Redox biology and gastric carcinogenesis: the role of Helicobacter pylori. Redox Rep. 2011;16(1):1-7. [DOI:10.1179/174329211X12968219310756] [PMID] [PMCID]

6. Ishiguro H, Kimura M, Takeyama H. Role of microRNAs in gastric cancer. World J Gastroenterol. 2014;20(19):5694-9. [DOI:10.3748/wjg.v20.i19.5694] [PMID] [PMCID]

7. Taft RJ, Pang KC, Mercer TR, Dinger M, Mattick JS. Non‐coding RNAs: regulators of disease. J Pathol. 2010;220(2):126-39. [DOI:10.1002/path.2638] [PMID]

8. Tüfekci KU, Meuwissen RLJ, Genç Ş. The role of microRNAs in biological processes. In miRNomics: microRNA biology and computational analysis. 2014. 1st ed. pp.15-31. Totowa, NJ, U.S.A.: Humana Press. [DOI:10.1007/978-1-62703-748-8_2] [PMID]

9. Shyu AB, Wilkinson MF, Van Hoof A. Messenger RNA regulation: to translate or to degrade. EMBO J. 2008;27(3):471-81. [DOI:10.1038/sj.emboj.7601977] [PMID] [PMCID]

10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215-33. [DOI:10.1016/j.cell.2009.01.002] [PMID] [PMCID]

11. Gracias DT, Katsikis PD. MicroRNAs: key components of immune regulation. In Crossroads between innate and adaptive immunity III. 2011. 1st ed. pp.:15-26. New York, NY, U.S.A.: Springer. [DOI:10.1007/978-1-4419-5632-3_2] [PMID]

12. Cadamuro ACT, Rossi AFT, Maniezzo NM, Silva AE. Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs. World J Gastroenterol. 2014;20(6):1424-37. [DOI:10.3748/wjg.v20.i6.1424] [PMID] [PMCID]

13. Libânio D, Dinis-Ribeiro M, Pimentel-Nunes P. Helicobacter pylori and microRNAs: Relation with innate immunity and progression of preneoplastic conditions. World J Clin Oncol. 2015;6(5):111-32. [DOI:10.5306/wjco.v6.i5.111] [PMID] [PMCID]

14. Hocès De La Guardia A, Staedel C, Kaafarany I, Clément A, Roubaud Baudron C, Mégraud F, et al. Inflammatory cytokine and microRNA responses of primary human dendritic cells cultured with Helicobacter pylori strains. Front Microbiol. 2013;4:236. [DOI:10.3389/fmicb.2013.00236] [PMID] [PMCID]

15. Zingone F, Pilotto V, Cardin R, Maddalo G, Orlando C, Fassan M, et al. Autoimmune atrophic gastritis: the role of miRNA in relation to Helicobacter pylori infection. Front Immunol. 2022;13:930989. [DOI:10.3389/fimmu.2022.930989] [PMID] [PMCID]

16. Shomali N, Mansoori B, Mohammadi A, Shirafkan N, Ghasabi M, Baradaran B. MiR-146a functions as a small silent player in gastric cancer. Biomed Pharmacother. 2017;96:238-45. [DOI:10.1016/j.biopha.2017.09.138] [PMID]

17. Yousefi L, Osquee HO, Ghotaslou R, Rezaee MA, Pirzadeh T, Sadeghi J, et al. Dysregulation of lncRNA in Helicobacter pylori-Infected Gastric Cancer Cells. Biomed Res Int. 2021;2021:6911734. [DOI:10.1155/2021/6911734] [PMID] [PMCID]

18. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207-10. [DOI:10.1093/nar/30.1.207] [PMID] [PMCID]

19. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47-e. [DOI:10.1093/nar/gkv007] [PMID] [PMCID]

20. Lim JY, Yoon SO, Seol S-Y, Hong SW, Kim JW, Choi SH, et al. Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. World J Gastroenterol. 2013;19(41):7078-88. [DOI:10.3748/wjg.v19.i41.7078] [PMID] [PMCID]

21. Badr MT, Omar M, Häcker G. Comprehensive Integration of Genome-Wide Association and Gene Expression Studies Reveals Novel Gene Signatures and Potential Therapeutic Targets for Helicobacter pylori-Induced Gastric Disease. Front Immunol. 2021;12:624117. [DOI:10.3389/fimmu.2021.624117] [PMID] [PMCID]

22. Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clinica Chimica Acta. 2013;424:53-65. [DOI:10.1016/j.cca.2013.05.002] [PMID]

23. Liu D, Ma X, Yang F, Xiao D, Jia Y, Wang Y. Discovery and validation of methylated-differentially expressed genes in Helicobacter pylori-induced gastric cancer. Cancer Gene Ther. 2020;27(6):473-85. [DOI:10.1038/s41417-019-0125-7] [PMID]

24. Mojtahedi A, Fakhrieh Asl S, Aminian K, Pourvahedi M, Saadat F, Fallah Karkan M. The association between iceA and vacA allelic gene variations of Helicobacter pylori strains and gastric disorders. Gene Rep. 2018;13:94-8. [DOI:10.1016/j.genrep.2018.09.006]

25. Reyes VE. Helicobacter pylori and Its Role in Gastric Cancer. Microorganisms. 2023;11(5):1312. [DOI:10.3390/microorganisms11051312] [PMID] [PMCID]

26. Yao Y, Suo A-L, Li Z-F, Liu L-Y, Tian T, Ni L, et al. MicroRNA profiling of human gastric cancer. Mol Med Rep. 2009;2(6):963-70.

27. Shao L, Chen Z, Peng D, Soutto M, Zhu S, Bates A, et al. Methylation of the HOXA10 Promoter Directs miR-196b-5p-Dependent Cell Proliferation and Invasion of Gastric Cancer Cells. Mol Cancer Res. 2018;16(4):696-706. [DOI:10.1158/1541-7786.MCR-17-0655] [PMID] [PMCID]

28. Liu S-G, Qin X-G, Zhao B-S, Qi B, Yao WJ, Wang T-Y, et al. Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett. 2013;5(5):1639-42. [DOI:10.3892/ol.2013.1251] [PMID] [PMCID]

29. Gao Y, Xie M, Guo Y, Yang Q, Hu S, Li Z. Long non-coding RNA FGD5-AS1 regulates cancer cell proliferation and chemoresistance in gastric cancer through miR-153-3p/CITED2 axis. Front genet. 2020;11:715. [DOI:10.3389/fgene.2020.00715] [PMID] [PMCID]

30. Song Y, Guo D, Liu J-F, Ge L-N, Liu P, Qu Y-M, et al. Downregulation of miR 7 and miR 153 is involved in Helicobacter pylori CagA induced gastric carcinogenesis and progression. Int J Oncol. 2023;63(1):1-14. [DOI:10.3892/ijo.2023.5527] [PMID] [PMCID]

31. Wang C, Hu Y, Yang H, Wang S, Zhou B, Bao Y, et al. Function of Non-coding RNA in Helicobacter pylori-Infected Gastric Cancer. Front Mol Biosci. 2021;8:649105. [DOI:10.3389/fmolb.2021.649105] [PMID] [PMCID]